title: Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
abstract: Prion diseases are fatal neurodegenerative disorders characterized by long incubation periods. To investigate whether concurrent diseases can modify the clinical outcome of prion-affected subjects, we tested the effect of viral infection on the binding and internalization of PrP(Sc), essential steps of prion propagation. To this effect, we added scrapie brain homogenate or purified PrP(Sc) to fibroblasts previously infected with minute virus of mice (MVM), a mouse parvovirus. We show here that the rate of incorporation of PrP(Sc) into MVM-infected cells was significantly higher than that observed for naïve cells. Immunostaining of cells and immunoblotting of subcellular fractions using antibodies recognizing PrP and LysoTracker, a lysosomal marker, revealed that in both control and MVM-infected cells the incorporated PrP(Sc) was associated mostly with lysosomes. Interestingly, flotation gradient analysis revealed that the majority of the PrP(Sc) internalized into MVM-infected cells shifted toward raft-containing low-density fractions. Concomitantly, the MVM-infected cells demonstrated increased levels of the glycosphingolipid GM1 (an essential raft lipid component) throughout the gradient and a shift in caveolin 1 (a raft protein marker) toward lighter membrane fractions compared with noninfected cells. Our results suggest that the effect of viral infection on membrane lipid composition may promote the incorporation of exogenous PrP(Sc) into rafts. Importantly, membrane rafts are believed to be the conversion site of PrP(C) to PrP(Sc); therefore, the association of exogenous PrP(Sc) with such membrane microdomains may facilitate prion infection.
authors.affiliation: Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel.
authors.forename: Dana
authors.initials: D
authors.lastname: Avrahami
authors.forename: Yael
authors.initials: Y
authors.lastname: Dayan-Amouyal
authors.forename: Saar
authors.initials: S
authors.lastname: Tal
authors.forename: Michal
authors.initials: M
authors.lastname: Mincberg
authors.forename: Claytus
authors.initials: C
authors.lastname: Davis
authors.forename: Oded
authors.initials: O
authors.lastname: Abramsky
authors.forename: Ruth
authors.initials: R
authors.lastname: Gabizon
mesh_terms: D000818:Animals; D001921:Brain / Q000378:metabolism / Q000821:virology; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism* / Q000821:virology*; D002478:Cells, Cultured; D006224:Cricetinae; D008563:Membrane Lipids / Q000378:metabolism* / Q000502:physiology; D008647:Mesocricetus; D051379:Mice; D008915:Minute Virus of Mice / Q000502:physiology*; D018620:PrPSc Proteins / Q000008:administration & dosage / Q000378:metabolism*; D017096:Prion Diseases / Q000378:metabolism / Q000821:virology
chemical_list: D008563:Membrane Lipids; D018620:PrPSc Proteins